MYD88 and metabolic dysfunction-associated steatohepatitis: In experimental animal models, attenuation of either liver fibrosis or liver inflammation was associated by reduced MyD88 expression in either nonalcoholic steatohepatitis related hepatic fibrosis [45] or chronic alcohol fed rats [46] respectively.